Event details
Date
Time
Duration
Available On-Demand
The use of natriuretic peptide testing in clinical practice provides information that may not be obvious at the patient’s bedside. This online seminar discusses the latest clinical application of natriuretic peptides, examining how testing may support clinical judgment, reduce cost, and decrease serious medical events. In addition, this seminar will include an exploration of the relationship between natriuretic peptide levels and guideline-directed medical therapy in the inpatient and outpatient settings.
Key Learning Objectives:
- Review the use of natriuretic peptide testing in the diagnosis and determination of disease severity in heart failure
- Identify the latest trends for use of natriuretic peptide testing in today’s clinical practice
- Examine the potential use of natriuretic peptides in relation to guideline-directed medical therapy
Who should attend?
Physicians, nurses, physician assistants, nurse practitioners, laboratorians, pathologists, biologists and medical technologists.
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Accreditation statement
SelectScience is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Attendees of this one-hour webinar are also entitled to 1.0 ACCENT Continuing Education Credits from the AACC. This activity was planned in accordance with ACCENT® Standards and Policies. Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email education@aacc.org.
Presenter
Dr. James Januzzi is the Adolph Hutter Professor of Medicine at Harvard Medical School, a staff cardiologist at the Massachusetts General Hospital, and the Chief Scientific Officer and C. Michael Gibson Chair at the Baim Institute for Clinical Research. He is a clinical trialist focused on optimizing diagnosis and treatment of cardiovascular diseases including heart failure and coronary artery disease. His work established the natriuretic peptides as the gold standard diagnostic biomarker for heart failure and is featured in clinical practice guidelines globally. He has published nearly 1,000 manuscripts and his work has been cited nearly 150,000 times.
Ellie studied biochemistry at the University of Nottingham, UK, and has previous experience working in management consultancy. As a member of the Editorial team, she now plays an integral role in shaping the content on SelectScience.